Braidwell’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Braidwell's RGEN Position: Q1 2026 in Review
Braidwell reduced its Repligen (RGEN) stake by 42% in Q1 2026, selling an estimated $4.79M and leaving 47,500 shares worth $5.6M. The position accounts for 0.19% of the portfolio, ranked #81.
Braidwell first reported a position in RGEN in Q2 2023 and has held it in 12 quarters since. The position peaked at $59M in Q3 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Braidwell held 47,500 shares of Repligen worth $5.6M as of Q1 2026.
- Braidwell sold 34,290 Repligen shares in Q1 2026, an estimated $4.79M.
- Repligen made up 0.19% of Braidwell's portfolio in Q1 2026, its #81 holding.
- Braidwell first reported a position in Repligen in Q2 2023 and has held it in 12 quarters since.
- Braidwell's Repligen position peaked at $59M in Q3 2024.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Braidwell's 13F filing for Q1 2026, filed 15 May 2026.